Literature DB >> 11220350

Sulphonylurea dose-response relationships: relation to clinical practice.

U Lindblad1, A Melander.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11220350     DOI： 10.1046/j.1463-1326.2000.00046.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  3 in total

1.  Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.

Authors:  A Holstein; A Plaschke; C Hammer; E-H Egberts
Journal:  Eur J Clin Pharmacol       Date:  2003-04-16       Impact factor: 2.953

Review 2.  The role of sulphonylureas in the management of type 2 diabetes mellitus.

Authors:  Marc Rendell
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.

Authors:  S Ristic; C Collober-Maugeais; E Pecher; F Cressier
Journal:  Diabet Med       Date:  2006-07       Impact factor: 4.359
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.